Scheme Completed
Beijing Guoci Kebo Technology Co. acquisition of SDI
A$166m equity value
Announced 27 Feb 2026 · ASX: SDI · A$1.40 cash per share · 58% premium
Advisers
Beijing Guoci Kebo Technology Co.
Acquirer
- Financial adviser
- Legal adviser
- Herbert Smith Freehills Kramer (as HSF Kramer)
- Target
- SDI
- Acquirer
- Beijing Guoci Kebo Technology Co. (Shandong Sinocera Functional Material Co.)
- Seller
- Jeffery James Cheetham
- Structure
- Scheme of arrangement
- Completed
- 6 Jul 2026
- Sector
- Medical devices and technology
In the league tables
- M&A financial advisers, 2026 to date Houlihan Lokey #31 · Rothschild & Co #31
- M&A financial advisers, completed, 2026 to date Houlihan Lokey #24 · Rothschild & Co #24
- M&A legal advisers, 2026 to date Herbert Smith Freehills Kramer #2 · DLA Piper #26
- M&A legal advisers, completed, 2026 to date Herbert Smith Freehills Kramer #3 · DLA Piper #27
Similar deals
- Thermo Fisher Scientific acquisition of Solventum purification and filtration (P&F) business Sep 2025 · A$6.2bn · Medical devices and technology
- Alcidion Group acquisition of Kyra flow products May 2026 · A$3m · Medical devices and technology
- Blackbird stake in Heidi Oct 2026 · Medical devices and technology
- Genetic Signatures and Microba Life Sciences merger Sep 2026 · Medical devices and technology
- Smartways Logistics acquisition of SAVI Surgical Feb 2026 · Medical devices and technology
Sources
- 27 Feb 2026 SDI Enters into a Scheme Implementation Deed ASX
- 6 Jul 2026 Implementation of the Scheme ASX